行情

ICAD

ICAD

ICAD US
NASDAQ

实时行情|Nasdaq Last Sale

9.41
-0.21
-2.18%
盘后: 9.41 0 0.00% 16:00 01/17 EST
开盘
9.73
昨收
9.62
最高
9.89
最低
9.30
成交量
12.49万
成交额
--
52周最高
9.89
52周最低
4.050
市值
1.82亿
市盈率(TTM)
-12.2414
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ICAD 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.52分钟前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.1小时前
  • 戈恩为何决定逃亡?日媒揭秘:或因听闻审理将延期
  • 中国新闻网.1小时前
  • 日媒:戈恩从日本逃往黎巴嫩或因听闻审理将延期
  • 新京报网.1小时前

更多

所属板块

先进医疗设备和技术
+0.57%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

ICAD 简况

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.
展开

Webull提供iCAD Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。